The purpose of this study is to assess the safety and effectiveness of DTG use in HIV positive pregnant women. This is a 3-year multi-site prospective observational study. Approximately, 250 HIV positive pregnant women from potential European AIDS Treatment Network (NEAT ID) sites across Europe will be enrolled. The enrollment period will be over 2 years with a follow-up period of 1 year for outcomes. The data collected will be that obtained during routine standard of care assessments; and the subjects will not undergo any interventional study procedures.
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of female subjects with spontaneous abortion
Timeframe: Up to 1 year
Number of female subjects with induced abortion
Timeframe: Up to 1 year
Number of female subjects giving still births
Timeframe: Up to 1 year
Number of female subjects with multiple births
Timeframe: Up to 1 year
Number of female subjects with type of deliveries
Timeframe: Up to 1 year
Maternal viral load (VL) at delivery
Timeframe: Up to 1 year
Number of infants with birth defects
Timeframe: Up to 1 year
Gestational age
Timeframe: Up to 1 year
Birth weight
Timeframe: Up to 1 year
Number of female subjects giving premature births
Timeframe: Up to 1 year
Number of female subjects giving live births
Timeframe: Up to 1 year
Infants with low birth weight
Timeframe: Up to 1 year
Appearance, Pulse, Grimace, Activity, Respiration (APGAR) score in infants
Timeframe: Up to 1 year
HIV status of Infants
Timeframe: Up to 1 year